Protagenic Therapeutics, Inc.\new Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Protagenic Therapeutics, Inc.\new quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2010 to Q3 2024.
  • Protagenic Therapeutics, Inc.\new Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 4.53M shares, a 4.58% increase year-over-year.
  • Protagenic Therapeutics, Inc.\new annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 4.34M shares, a 0.62% increase from 2022.
  • Protagenic Therapeutics, Inc.\new annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 4.32M shares, a 17.2% increase from 2021.
  • Protagenic Therapeutics, Inc.\new annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 3.69M shares.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 4.53M +198K +4.58% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 4.44M +112K +2.59% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 4.44M +117K +2.72% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 4.34M +26.7K +0.62% Oct 1, 2023 Dec 31, 2023 10-K/A 2024-05-14
Q3 2023 4.33M +9.64K +0.22% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 4.33M +10.8K +0.25% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 4.32M +9.46K +0.22% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 4.32M +633K +17.2% Oct 1, 2022 Dec 31, 2022 10-K/A 2024-05-14
Q3 2022 4.32M -12.2M -73.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 4.32M -10.2M -70.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 4.31M -6.21M -59% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 3.69M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 16.5M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 14.5M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 10.5M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q1 2015 400M 0 0% Jan 1, 2015 Mar 31, 2015 10-Q 2015-05-11
Q4 2014 400M 0 0% Oct 1, 2014 Dec 31, 2014 10-Q 2015-02-06
Q3 2014 400M 0 0% Jul 1, 2014 Sep 30, 2014 10-Q 2014-11-13
Q2 2014 400M Apr 1, 2014 Jun 30, 2014 10-K 2014-10-14
Q1 2014 400M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 400M Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-06
Q3 2013 400M Jul 12, 2013 Sep 30, 2013 10-Q 2014-11-13
Q3 2011 6.3M +1.08M +20.8% Jul 1, 2011 Sep 30, 2011 10-Q 2011-11-14
Q2 2011 6.32M +1.1M +21.1% Apr 1, 2011 Jun 30, 2011 10-Q/A 2011-09-07
Q3 2010 5.22M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 5.22M Apr 1, 2010 Jun 30, 2010 10-Q/A 2011-09-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.